MARTIN J TYLER 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Feb 23, 2010
Insider Transaction Report
Form 4
MARTIN J TYLER
VP Clinical Development & CMO
Transactions
- Award
Option (Right to Buy)
2010-02-19+50,000→ 50,000 totalExercise: $1.58Exp: 2020-02-18→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]This option grant shall vest upon achievement of certain performance conditions.
- [F2]Not applicable.